Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2026 12:16 ET (31-Oct-2026 16:16 GMT/UTC)
A real-world study of 145 resectable NSCLC patients who achieved pathological complete response after neoadjuvant chemoimmunotherapy found no significant disease-free or overall survival benefit from adding adjuvant immunotherapy. The findings suggest that patients with a pCR may not need further postoperative treatment, though larger prospective studies are required for confirmation.
A research team from Fujita Health University, Japan, engineered a lab-grown model of heart failure with preserved ejection fraction (HFpEF), where the heart’s relaxation function is impaired. Human induced pluripotent stem cell-derived tissues were cultured in a medium with abundant fatty acids and L-NG-nitroarginine methyl ester. This model was used to study HFpEF’s underlying disease processes and treatment options. Among the current treatment options tested, the antidiabetic SGLT2 inhibitors showed improvement in relaxation function.
Scientists at Peking University have identified a mitochondrial protein that is essential for protecting motor neurons, offering new insight into how amyotrophic lateral sclerosis (ALS) may develop. The study, led by Dr. Xianhua Wang and Dr. Heping Cheng at the College of Future Technology, Peking University, shows that loss of the mitochondrial protein ROMO1 causes progressive damage to motor neurons and muscles in mice, closely resembling key features of human ALS. The findings were published online in Science Bulletin.
A research team led by Prof. Yi Sun at Zhejiang University, reported a unexpected finding that the combination of KrasG12D activation and genetic inactivation of UBE2M in the lung triggers the cGAS-STING-NF-κB signal to form a inflammatory tumor microenvironment (TME). Mechnistically, KrasG12D promotes the mitochondrial biogenesis, whereas UBE2M depletion inhibits Parkin neddylation and mitophagy, together causing the cytoplasmic release of damaged mitochondrial DNA. The STING antagonist H-151 rescues TME, indicating a causal role of the cGAS-STING signal. The study therefore demonstrates a unexpected role of UBE2M in prevention TME induced by Kras mutant.
As it tries to defend itself from stroke, the brain can paradoxically trigger the formation of tiny new clots in minor blood vessels, damaging tissue even after the original culprit has been removed, new research shows. The findings help explain why nearly half of treated stroke patients don’t recover — and identify potential new treatments.
As a new member of BLOODPAC, a leading international consortium on liquid biopsy, the Josep Carreras Leukaemia Research Institute will contribute to advancing liquid biopsy research and developing standards and validation protocols, with the aim of bringing this knowledge back to the Catalan and Spanish health system.
The Josep Carreras Institute becomes the first Spanish institution to become part of this prominent international consortium, contributing its expertise in blood cancers research to a global network of academic, industry and regulatory stakeholders.
Prolonged health uncertainty does not always stay in clinics or medical appointments. It can become part of everyday life, shaping work, relationships, identity, and the ability to imagine the future even when a person continues to function outwardly.
In a new analytic autoethnography, Mehmed Zahid Çögenli examined his own experience of living and working through prolonged health uncertainty. The analysis drew on approximately 1,150 lines of contemporaneous reflective writing, together with retrospective accounts and selected self-narrative documents, and used the concept of biographical disruption to understand how uncertainty entered ordinary life.
Four connected themes were identified: health uncertainty beyond the clinic; carrying competence under strain; silence, disclosure, and institutional vulnerability; and rebuilding a livable future. The study argues that continued productivity can conceal substantial invisible effort, and that prolonged uncertainty can become an occupational and relational burden even before medical clarity is reached.